XyloCor Therapeutics is a development-stage, biotechnology company dedicated to developing first-in-class gene therapies for patients with unmet medical need in cardiovascular disease.
View Top Employees from XyloCor Therapeutics, Inc.Website | http://xylocor.com |
Revenue | $202000 |
Employees | 19 (12 on RocketReach) |
Founded | 2013 |
Address | 1200 Liberty Ridge Drive Suite 120, Wayne, Pennsylvania 19087, US |
Phone | (888) 290-0081 |
Technologies |
HTML,
Google Analytics,
reCAPTCHA
+5 more
(view full list)
|
Industry | Research Services, Business Services General, Biotechnology, Business Services, Science and Engineering, Pharmaceutical, Health Care |
Competitors | Collateral Therapeutics Inc, Renova Therapeutics, SmartPharm Therapeutics, Inc., Unicycive Therapeutics |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 541714 Companies, NAICS Code 541 Companies |
Looking for a particular XyloCor Therapeutics, Inc. employee's phone or email?
The XyloCor Therapeutics, Inc. annual revenue was $202000 in 2024.
Alexander Gaidamaka is the Chief Technology Officer and Head of Technical Operations of XyloCor Therapeutics, Inc..
12 people are employed at XyloCor Therapeutics, Inc..
XyloCor Therapeutics, Inc. is based in Wayne, Pennsylvania.
The NAICS codes for XyloCor Therapeutics, Inc. are [54, 5417, 54171, 541714, 541].
The SIC codes for XyloCor Therapeutics, Inc. are [87, 873].